Provided by Tiger Fintech (Singapore) Pte. Ltd.

IGM Biosciences

1.27
0.0000
Volume:- -
Turnover:- -
Market Cap:76.57M
PE:-1.44
High:1.27
Open:1.27
Low:1.27
Close:1.27
52wk High:22.50
52wk Low:0.9200
Shares:60.29M
Float Shares:12.89M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.8789
EPS(LYR):-3.2355
ROE:-47.82%
ROA:2.89%
PB:0.76
PE(LYR):-0.39

Loading ...

IGM Biosciences Merges with Concentra Biosciences

TIPRANKS
·
Aug 15

IGM Biosciences Announces Delisting from Nasdaq Following Merger Completion

Reuters
·
Aug 15

Top Executives at IGM Biosciences Make Significant Stock Sales!

TIPRANKS
·
Jul 26

IGM Biosciences' Chief Business Officer Lisa Lynn Decker Reports Disposal of Common Shares

Reuters
·
Jul 26

Pulse Biosciences Inc. Appoints Steven T. Weber as Vice President of Accounting and Principal Accounting Officer

Reuters
·
Jul 15

Wedbush Cuts Price Target on IGM Biosciences to $1.25 From $3, Keeps Neutral Rating

MT Newswires Live
·
Jul 02

Sector Update: Health Care Stocks Rise in Late Afternoon Trading

MT Newswires Live
·
Jul 02

IGM Biosciences moved to No Rating at BofA

TIPRANKS
·
Jul 02

IGM Biosciences to Be Acquired by Concentra Biosciences for $1.247 Per Share Plus Contingent Value Rights

Reuters
·
Jul 01

IGM Biosciences Inc. Chief Business Officer Lisa Lynn Decker Reports Disposal of Common Shares

Reuters
·
Jun 21

IGM Biosciences Faces Nasdaq Non-Compliance Notice

TIPRANKS
·
Jun 12

IGM Biosciences Inc. Faces Nasdaq Delisting Risk Due to Non-Compliance with $50M Market Value Requirement

Reuters
·
Jun 12

IGM Biosciences Is Maintained at Hold by Truist Securities

Dow Jones
·
Jun 12

Analysts Offer Insights on Healthcare Companies: Merus (MRUS) and IGM Biosciences (IGMS)

TIPRANKS
·
Jun 11

Truist Cuts Price Target on IGM Biosciences to $1 From $2, Keeps Hold Rating

MT Newswires Live
·
Jun 11

IGM Biosciences Reports Increased Net Loss Amid Strategic Focus

TIPRANKS
·
Jun 03

IGM Biosciences Inc. Principal Accounting Officer Steven Weber Reports Disposal of Common Shares

Reuters
·
May 17

IGM Biosciences Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 15

IGM Biosciences Q1 EPS $(0.50) Misses $(0.48) Estimate, Sales $499.00K Miss $3.10M Estimate

Benzinga
·
May 14

BRIEF-Igm Biosciences Inc Says On May 5, Co Received Notice Of Termination Genzyme Corp That Certain Collaboration And License Agreement

Reuters
·
May 09